EMANUEL CHRIS: Open Payments
NPI 1326086547 · WALPOLE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,203 in 161 payments from 18 companies in 2025. Trend: 2023 $2,101 · 2024 $2,487 · 2025 $3,203
Food & beverage: $3,072Education: $132
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 30 | $428 |
| Vanda Pharmaceuticals Inc. | 28 | $405 |
| ABBVIE INC. | 17 | $324 |
| Lundbeck LLC | 12 | $312 |
| Otsuka America Pharmaceutical, Inc. | 10 | $295 |
| Teva Pharmaceuticals USA, Inc. | 10 | $285 |
| Tris Pharma Inc | 14 | $236 |
| Alkermes, Inc. | 8 | $160 |
| Corium, LLC | 5 | $124 |
| Axsome Therapeutics, Inc. | 5 | $117 |
Products named: REXULTI, CAPLYTA, FANAPT, VRAYLAR, Dyanavel XR, AUSTEDO XR, ARISTADA, Azstarys.
Industry payments across MA — which companies pay providers there.
